CAI Q1 2017 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+21.7% YoY

Gross Profit

$36M44.7% margin

Operating Income

$19M23.1% margin

Net Income

$5M6.5% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

-$23M

Stock-Based Comp.

$461,000

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.6B

Stockholders' Equity

$465M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$67M	+21.7%
Gross Profit	$36M	$37M	-1.4%
Operating Income	$19M	$19M	-1.9%
Net Income	$5M	$7M	-26.4%